Burroughs et al. (1985) found that 15 patients with liver cirrhosis who received 0.3 mg/kg of DDAVP had significantly shortened in vitro bleeding time as well as improvements in APTT, FVIII activity, and VWF:Ag and VWF:RCo activity [81]. The gene discussed is VWF; the disease is cirrhosis of liver.